One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v126.23.59.59
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 7 |
Affiliation: Guy's and St Thomas' NHS Foundation Trust, University of Florence, Délégation Paris 7, Hôpital Saint-Louis, Université Paris Cité, Leipzig University, Medical University of Vienna, Cliniques Universitaires Saint-Luc, de Duve Institute, University of Barcelona, Incyte (United States), Novartis (France), Novartis (Switzerland), Ospedale Papa Giovanni XXIII
Long-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
